Retension Pharmaceuticals, Inc. RTSN
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.18% | -13.80% | 0.00% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 733.11% | -87.57% | 0.00% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -2.90% | -22.55% | 0.00% | ||
|
|
|||||
| Total Current Assets | -2.90% | -22.55% | 0.00% | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -2.90% | -22.55% | 0.00% | ||
|
|
|||||
| Total Accounts Payable | 80.26% | 99.64% | 0.00% | ||
| Total Accrued Expenses | -6.19% | -34.85% | 0.00% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 75.57% | 79.54% | 0.00% | ||
|
|
|||||
| Total Current Liabilities | 75.57% | 79.54% | 0.00% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 75.57% | 79.54% | 0.00% | ||
|
|
|||||
| Common Stock & APIC | 19.18% | 44.73% | 0.00% | ||
| Retained Earnings | -13.36% | -68.05% | 0.00% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -13.02% | -69.64% | 0.00% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 0.00% | -0.50% | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 0.00% | -0.50% | 0.00% | ||
|
|
|||||
| Total Common Equity | -13.02% | -69.64% | 0.00% | ||
| Total Preferred Equity | 0.00% | -0.50% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -11.48% | -27.09% | 0.00% | ||
|
|
|||||